These results allowed us to propose that in the early stages of inflammatory arthritis, VEGF levels might allow us to differentiate patients whose CRP is elevated due to active infection and those to whom it might be elevated because of active arthritis, and it would help to introduce treatment with DMARDs earlier. This evidence concerns the gene CRP and arthritic joint disease.